|
|
|
|
| LEADER |
02854nam a2200745 4500 |
| 001 |
ocn867001329 |
| 003 |
OCoLC |
| 005 |
20170124070009.4 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
131230s2014 enk ob 001 0 eng |
| 010 |
|
|
|a 2013051093
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d YDX
|d DG1
|d N$T
|d E7B
|d CUS
|d YDXCP
|d OCLCF
|d NLGGC
|d OCLCO
|d VLB
|d COO
|d OCLCQ
|d OCLCO
|d DG1
|d GrThAP
|
| 020 |
|
|
|a 9781118494028
|q (epub)
|
| 020 |
|
|
|a 1118494024
|q (epub)
|
| 020 |
|
|
|a 9781118494011
|q (pdf)
|
| 020 |
|
|
|a 1118494016
|q (pdf)
|
| 020 |
|
|
|a 9781118493984
|q (electronic bk.)
|
| 020 |
|
|
|a 1118493982
|q (electronic bk.)
|
| 020 |
|
|
|a 1118275756
|
| 020 |
|
|
|a 9781118275757
|
| 020 |
|
|
|z 9781118275757
|q (cloth)
|
| 029 |
1 |
|
|a DEBBG
|b BV042796338
|
| 029 |
1 |
|
|a NLGGC
|b 375066535
|
| 029 |
1 |
|
|a NZ1
|b 15906709
|
| 035 |
|
|
|a (OCoLC)867001329
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC669
|
| 060 |
1 |
0 |
|a QV 180
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.1/061
|2 23
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Antiplatelet therapy in cardiovascular disease /
|c edited by Ron Waksman, Paul A. Gurbel, Michael A. Gaglia, Jr.
|
| 264 |
|
1 |
|a Chichester, West Sussex :
|b Wiley-Blackwell,
|c 2014.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record and CIP data provided by publisher.
|
| 650 |
|
0 |
|a Cardiovascular system
|x Diseases
|x Chemotherapy.
|
| 650 |
|
0 |
|a Anticoagulants (Medicine)
|
| 650 |
|
2 |
|a Cardiovascular Agents
|x therapeutic use.
|
| 650 |
|
2 |
|a Platelet Aggregation Inhibitors
|x therapeutic use.
|
| 650 |
|
2 |
|a Cardiovascular Diseases
|x blood.
|
| 650 |
|
2 |
|a Cardiovascular Diseases
|x drug therapy.
|
| 650 |
|
2 |
|a Platelet Function Tests.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Anticoagulants (Medicine)
|2 fast
|0 (OCoLC)fst00810468
|
| 650 |
|
7 |
|a Cardiovascular system
|x Diseases
|x Chemotherapy.
|2 fast
|0 (OCoLC)fst00847184
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Waksman, Ron,
|e editor.
|
| 700 |
1 |
|
|a Gurbel, Paul A.,
|e editor.
|
| 700 |
1 |
|
|a Gaglia, Michael A.,
|c Jr,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Antiplatelet therapy in cardiovascular disease.
|d Chichester, West Sussex : John Wiley & Sons, 2014
|z 9781118275757
|w (DLC) 2013049556
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118493984
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
